| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Restricted Stock Unit | 60K | $69.6K | $1.16 | Jan 23, 2025 | Direct |
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Common Stock | 26.3K | $23.2K | $0.88 | Dec 23, 2024 | Direct |
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Restricted Stock Units | 0 | $0 | $0.82 | Dec 23, 2024 | Direct |
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Stock Option (right to buy) | 65K | Jan 23, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | Jan 23, 2025 | 2 | $0 | 4 | Jan 27, 2025 | Chief Medical Officer |
| GALT | GALECTIN THERAPEUTICS INC | Dec 23, 2024 | 3 | -$12K | 4 | Dec 26, 2024 | Chief Medical Officer |
| GALT | GALECTIN THERAPEUTICS INC | Aug 2, 2024 | 0 | $0 | 3 | Aug 5, 2024 | Chief Medical Officer |
| GALT | GALECTIN THERAPEUTICS INC | Aug 1, 2024 | 2 | $0 | 4 | Aug 5, 2024 | Chief Medical Officer |